A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation research

Anna Lembke; Keith Humphreys

doi:10.1136/tobaccocontrol-2014-052215

A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation research

Tob Control. 2016 May;25(3):261-2. doi: 10.1136/tobaccocontrol-2014-052215. Epub 2015 Apr 16.

Authors

Anna Lembke¹, Keith Humphreys²

Affiliations

¹ Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Stanford, California, USA.
² Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Stanford, California, USA Center for Innovation to Implementation, VA Palo Alto Health Care System.

PMID: 25882685
DOI: 10.1136/tobaccocontrol-2014-052215

Abstract

This commentary points out that smoking is increasingly concentrated among people with psychiatric problems and other substance use disorders (eg, alcohol use disorder), and argues that for clinical, ethical and efficiency reasons, such individuals should be routinely enrolled in smoking cessation research.

Keywords: Co-substance use; Disparities; Priority/special populations.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Clinical Trials as Topic / ethics
Clinical Trials as Topic / methods*
Drug Users / psychology*
Humans
Mental Disorders / psychology*
Patient Selection* / ethics
Research Subjects / psychology*
Smoking / adverse effects
Smoking / psychology
Smoking Cessation / methods*
Smoking Cessation / psychology
Smoking Prevention*